GANZETTI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 4.325
EU - Europa 2.527
AS - Asia 1.875
SA - Sud America 473
AF - Africa 139
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 9.351
Nazione #
US - Stati Uniti d'America 4.246
SG - Singapore 513
VN - Vietnam 425
UA - Ucraina 414
BR - Brasile 389
IT - Italia 379
RU - Federazione Russa 365
CN - Cina 349
DE - Germania 248
FR - Francia 240
IE - Irlanda 217
SE - Svezia 215
TR - Turchia 164
DK - Danimarca 141
FI - Finlandia 126
HK - Hong Kong 116
GB - Regno Unito 99
KR - Corea 80
CI - Costa d'Avorio 78
IN - India 73
MX - Messico 34
AR - Argentina 32
BD - Bangladesh 32
CA - Canada 27
ZA - Sudafrica 23
IQ - Iraq 19
JP - Giappone 18
PL - Polonia 16
CO - Colombia 14
ID - Indonesia 14
MA - Marocco 13
NL - Olanda 13
EC - Ecuador 11
ES - Italia 11
PK - Pakistan 10
UZ - Uzbekistan 10
RO - Romania 9
JM - Giamaica 8
AU - Australia 7
KZ - Kazakistan 7
PY - Paraguay 7
VE - Venezuela 7
CL - Cile 6
LT - Lituania 6
MY - Malesia 6
CH - Svizzera 5
DZ - Algeria 5
EU - Europa 5
KE - Kenya 5
PH - Filippine 5
HR - Croazia 4
PE - Perù 4
TH - Thailandia 4
AT - Austria 3
CZ - Repubblica Ceca 3
ET - Etiopia 3
NP - Nepal 3
SA - Arabia Saudita 3
SN - Senegal 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BH - Bahrain 2
CR - Costa Rica 2
CY - Cipro 2
EG - Egitto 2
HN - Honduras 2
IL - Israele 2
JO - Giordania 2
KG - Kirghizistan 2
KW - Kuwait 2
OM - Oman 2
PT - Portogallo 2
SM - San Marino 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AZ - Azerbaigian 1
BB - Barbados 1
BO - Bolivia 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
IR - Iran 1
KH - Cambogia 1
LK - Sri Lanka 1
LY - Libia 1
MT - Malta 1
NG - Nigeria 1
PA - Panama 1
PR - Porto Rico 1
TW - Taiwan 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
ZW - Zimbabwe 1
Totale 9.351
Città #
Ashburn 558
Jacksonville 402
Chandler 378
Fairfield 315
Singapore 298
Dallas 281
Dublin 216
Boardman 192
Wilmington 146
New York 138
Woodbridge 134
Ho Chi Minh City 133
Houston 125
San Jose 120
Hong Kong 116
Seattle 109
Hanoi 94
Cambridge 93
Beijing 87
San Mateo 86
Lawrence 82
Princeton 82
Abidjan 78
The Dalles 78
Centro 74
Los Angeles 72
Lauterbourg 69
Munich 60
Ann Arbor 50
Moscow 49
São Paulo 49
Hefei 43
Buffalo 37
Turku 35
San Diego 31
Turin 31
London 30
Da Nang 28
Orem 28
Haiphong 26
Pune 25
Des Moines 20
Porto 19
Guangzhou 18
Helsinki 18
Milan 18
Shanghai 18
Marche 16
Rome 15
Johannesburg 14
Santa Clara 14
Warsaw 13
Norwalk 12
Rio de Janeiro 12
Chennai 11
Chicago 11
Boston 10
Denver 10
Phoenix 10
Tokyo 10
Wuhan 10
Council Bluffs 9
Kilburn 9
Montreal 9
Poplar 9
Ancona 8
Atlanta 8
Mexico City 8
Tashkent 8
Toronto 8
Baghdad 7
Belo Horizonte 7
Brooklyn 7
Charlotte 7
Frankfurt am Main 7
Jiaxing 7
Kolkata 7
Naples 7
Thái Bình 7
Amsterdam 6
Cagliari 6
Civitanova Marche 6
Guarulhos 6
Jinhua 6
Manchester 6
Salvador 6
Almaty 5
Bauru 5
Biên Hòa 5
Bogotá 5
Bắc Giang 5
Dhaka 5
Elk Grove Village 5
Fortaleza 5
Hanover 5
Hải Dương 5
Kingston 5
Kyiv 5
Nairobi 5
Nuremberg 5
Totale 5.608
Nome #
Active inflammatory biomarkers in oral lichen planus 198
Adipochine e citochine proinfiammatorie nella psoriasi: ruolo modulante di Etanercpet 183
A patient with psoriasis and vitiligo treated with etanercept 176
Helicobacter pylori infection in psoriasis: results of a clinical study and review of the literature 169
Adalimumab modulates angiogenesis in psoriatic skin 169
Efficacy and Safety of Topical Pidobenzone 4% as Adjuvant Treatment for Solar Lentigines: Result of a Randomized, Controlled, Clinical Trial 158
A non-responsive chronic autoimmune urticaria in a 12-year-old autistic girl treated with cyclosporin. 156
Biologic Therapy in Inflammatory and Immunomediated Skin Diseases: Safety Profile 155
T helper (Th)1, Th17 and Th2 imbalance in mesenchymal stem cells of adult patients with atopic dermatitis: At the origin of the problem 151
Homocysteine plasma levels in psoriasis patients: our experience and review of the literature 150
Characterization and profiling of immunomodulatory genes in resident mesenchymal stem cells reflect the Th1-Th17/Th2 imbalance of psoriasis 149
Diagnostic and prognostic role of nicotinamide N-methyltransferase in cutaneous malignant melanoma 147
Electrochemotherapy: an effective local treatment of cutaneous and subcutaneous melanoma metastases 145
TNF-α inhibitors reduce the pathological Th1 -Th17 /Th2 imbalance in Cutaneous Mesenchymal Stem Cells of psoriasis patients. 145
Angiogenesis in psoriatic skin and its modifications after administration of etanercept: videocapillaroscopic, histological and immunohistochemical evaluation. 142
Biologic Therapy in Psoriasis: Safety Profile 140
A validation study of the Simple Psoriatic Arthritis Screening (SiPAS) questionnaire to screen psoriasis patients for psoriatic arthritis 138
Onabotulinumtoxin type A (Botox(®)) versus Incobotulinumtoxin type A (Xeomin(®)) in the treatment of focal idiopathic palmar hyperhidrosis: results of a comparative double-blind clinical trial 137
The effect of low-carbohydrates calorie-restricted diet on visceral adipose tissue and metabolic status in psoriasis patients receiving TNF-alpha inhibitors: results of an open label controlled, prospective, clinical study 137
Bullous pemphigoid of Lever and celiac disease: a coincidental occurrence or an unusual association? 134
Certolizumab pegol for the treatment of psoriasis 134
Alopecia Areata: a possible extraintestinal manifestation of Crohn's disease. 132
Dermoscopic features of conjunctival melanocytic lesions 131
Biologic Therapy in Immune Mediated Inflammatory Disease: Basic Science and Clinical Concepts 130
Response to letter to the editor: 'a precise knowledge of ozonated oils will help to define the favourable and peculiar properties of these functional dermatological matrices' 130
CTACK /CCL27 expression in psoriatic skin and its modification after administration of etanercept. 129
Skin features in myotonic dystrophy type 1: An observational study 129
Purely cutaneous Langerhans' cell histiocytosis in an adult woman 127
Elastosis perforans serpiginosa: a case successfully treated with intralesional steroids and topical allium cepa-allantoin-pentaglycan gel 127
Role of mesenchymal stem cells in the pathogenesis of psoriasis: current perspectives 127
The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis. 124
The transitioning from conventional therapy to biological treatment in psoriatic patients: STRATOS, a project of Marche Region 124
Primary cutaneous large cell lymphoma CD30+: a case-based review 124
Finally, recurrent pyoderma gangrenosum treated with Adalimumab: case report and review of the literature 124
Treatment of palmar hyperhidrosis with botulinum toxin type A: results of a pilot study based on a novel injective approach. 122
Ingenol mebutate in actinic keratosis: A clinical, videodermoscopic and immunohistochemical study 121
Bullous pemphigoid: Italian guidelines adapted from the EDF/EADV guidelines 121
Factitious disorders in adults: two cases of unusual skin ulcers 118
Doxycycline-Isoniazid: a new therapeutic association for recalcitrant acne agminata 118
The successful off-label use of photodynamic therapy for classic Porokeratosis of Mibelli:case report" 115
The potential effect of the tumour necrosis factor-α inhibitors on vitamin D status in psoriatic patients 114
Relapsing acute generalized exanthematous pustolosis: a guess. 114
Nicotinamide N-methyltransferase: a new potential biomarker for cutaneous malignant melanoma 110
Lifelong widespread warts associated with human papillomavirus type 70/85: a new diagnostic entity? 109
Microvessel density and VEGF, HIF-1α expression in primary oral melanoma: correlation with prognosis 109
Effect of Allium Cepa-Allantoin-Pentaglycan Gel on Skin Hypertrophic Scars: Clinical and Video-Capillaroscopic Results of an Open-Label, Controlled, Nonrandomized Clinical Trial. 106
Serum and tissue CTACK/CCL27 chemokine levels in early mycosis fungoides may be correlated with disease-free survival following treatment with interferon alfa and psoralen plus ultraviolet A therapy. 106
IL-17, IL-23, and p73 expression in cutaneous melanoma: a pilot study 106
Mycosis Fungoides-like Eruption and Infliximab 106
Lesional skin chemokine CTAK/CCL27 expression in mycosis fungoides and disease control by IFN-A and PUVA therapy. 105
The switching from a biological therapy to another biologic agent in psoriatic patients: the experience of PsOMarche group 105
Hidradenoma papilliferum: diagnostic challenge 103
Comparison of clinical and ultrasound scores in patients with hidradenitis suppurativa: results from an Italian ultrasound working group 103
Use of infliximab in toxic epidermal necrolysis: a still opened challenge 102
In vitro activity of Tachyplesin III alone and in combination with terbinafine against clinical isolates of dermatophytes. 101
In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents. 101
Hemangioma in POEMS syndrome:an atypical clinical and histological presentation 99
The effect of etanercept on vascular endothelial growth factor production by cutaneous mesenchymal stem cells from patients with psoriasis. 99
Insulin resistance, serum insulin and HOMA-R 95
Treatment of focal idiopathic hyperhidrosis with botulinum toxin type-A: clinical predictive factors of relapse free survival 94
Cutaneous CCL27 expression in early-stage mycosis fungoides: its role in the balance between the tumoral infiltrate and anti-tumoral immune response, and prognostic utility as a predictor of recurrence. 91
VEGF, survivin and NOS overexpression in psoriatic skin: Critical role of nitric oxide synthases 90
Tossicità cutanea da inibitori dell’Epidermal Growth Factor Receptor (EGFR): valutazione clinico-istologica ed approccio terapeutico 90
Periodontal Disease: An Oral Manifestation of Psoriasis or an Occasional Finding? 89
Videocapillaroscopic pattern of Alopecia Areata before and after diphenylciclopropenone treatment. 89
Non-alcoholic fatty liver disease and psoriasis: So far, so near 89
Normolipemic plane xanthomatosis with acute development preceding the clinical onset of rheumatoid arthritis 88
Osteopontin: a new facilitating factor in alopecia areata pathogenesis? 87
Rosacea: could topical azelaic acid and oral tetracyclines modify videocapillaroscopic pattern? 86
In vitro activity of the lipopetide derivative (Pal-lys-lysNh2), alone and in combination with antifungal agents, against clinical isolates of dermatophytes 85
Serum levels of adipocytokines in psoriasis patients receiving tumor necrosis factor-α inhibitors: Results of a retrospective analysis 85
Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background 84
Phototherapy in Dermatology 83
Reciprocal altered expression of E-Cadherin in mucous membrane pemphigoid. 82
La qualità della vita nel paziente psoriasico: esperienza di due anni del centro Psocare della Clinica Dermatologica di Ancona. 81
Possibile ruolo delle molecole di adesione cellula-cellula nei meccanismi patogenetici del pemfigo volgare 81
Metabolic Features in Psoriasis 80
Possibile ruolo delle molecole di adesione nei meccanismi patogenetici delle lesioni bollose nei pemfigoidi 77
Topical ozonated oil versus hyaluronic gel for the treatment of partial- to full-thickness second-degree burns: A prospective, comparative, single-blind, non-randomised, controlled clinical trial. 76
SERUM LEVELS OF TH1 AND TH2 CHEMOKINES IN CUTANEOUS T CELL LYMPHOMAS (CTCL) 70
Phototherapy as a useful therapeutic option in the treatment of diphenylcyclopropenone-induced vitiligo 70
Inflammatory bowel diseases and the skin: a monography 67
Totale 9.493
Categoria #
all - tutte 44.472
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.472


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021283 0 0 0 0 0 0 0 0 0 96 143 44
2021/2022606 38 166 17 22 4 31 31 44 32 47 63 111
2022/20231.124 103 142 103 82 78 124 1 77 295 6 85 28
2023/2024707 119 17 51 91 109 165 15 23 2 17 7 91
2024/20251.203 181 104 30 14 57 20 103 28 269 77 149 171
2025/20263.134 256 258 277 401 376 239 537 289 253 248 0 0
Totale 9.493